Total (980 cases) | Success treatment | Lost to follow-up | Failure | Death | ||||||
---|---|---|---|---|---|---|---|---|---|---|
N | % | N | % | N | % | N | % | N | % | |
Block III | ||||||||||
Resides in different municipality than treatment | ||||||||||
Yes | 414 | 42.2 | 273 | 65.9 | 56 | 13.5 | 38 | 9.2 | 47 | 11.4 |
No | 566 | 57.8 | 348 | 61.5 | 107 | 18.9 | 38 | 6.7 | 73 | 12.9 |
Reported unfavorable clinical evaluation | ||||||||||
Yes | 215 | 21.9 | 75 | 34.9 | 49 | 22.8 | 52 | 24.2 | 39 | 18.1 |
No | 765 | 78.1 | 546 | 71.4 | 114 | 14.9 | 24 | 3.1 | 81 | 10.6 |
Changed regimen type | ||||||||||
Yes | 154 | 15.7 | 109 | 70.8 | 17 | 11.0 | 16 | 10.4 | 12 | 7.8 |
No | 826 | 84.3 | 512 | 62.0 | 146 | 17.7 | 60 | 7.3 | 108 | 13.1 |
Had adverse reaction | ||||||||||
No adverse reaction records | 757 | 77.2 | 459 | 60.6 | 142 | 18.8 | 57 | 7.5 | 99 | 13.1 |
Only minor adverse reactions | 158 | 16.1 | 114 | 72.2 | 14 | 8.9 | 17 | 10.8 | 13 | 8.2 |
At least one major adverse reaction | 65 | 6.6 | 48 | 73.8 | 7 | 10.8 | 2 | 3.1 | 8 | 12.3 |
Total | 980 | 100.0 | 621 | 63.4 | 163 | 16.6 | 76 | 7.8 | 120 | 12.2 |